Led by Caroline Huber, Associate Director of Policy and Economics, a surprising new study was recently published in The Journal of Infectious Diseases, estimating the overlooked social, economic and health impacts of the 2013-2016 West Africa Ebola crisis.
VETERAN STRATEGIST CHOSEN TO LEAD INNOVATIVE HEALTH ECONOMICS,
MARKET ACCESS, AND PAYER ANALYTICS CONSULTANCY
Bethesda, MD – November 7, 2018 – Precision Xtract, part of Precision Value & Health, today announced Zac Stillerman, acclaimed healthcare industry operator and strategist, as new president and general manager. Responsible for leading Precision Xtract through its next phase of growth, Stillerman has a proven ability to translate vision and strategy into dynamic collaboration and first-class execution. He joins Precision Xtract at a time of growing demand from innovative life sciences companies for essential consulting activities, […]
Payers can face challenges in using appropriate management strategies close to launch. It’s difficult to have a complete picture of a therapy or device when manufacturers hesitate sharing certain information amid unclear FDA regulations. […]
As part of Precision Value & Health, we are excited to announce that we have been ranked #6 in MM&M magazine’s 2018 Agency Top 100 list. With a 10.6% increase in revenue from the previous year, we are continuing to add talent and services–partnering with pharmaceutical and life sciences companies to ensure patient access to life-changing therapies.
At the ASCO Annual Meeting in Chicago, PHE Senior Director, Policy & Economics Julia Thornton-Snider, PhD presented a recently-completed study on the impact of treatment delays for patients with pediatric leukemia. […]
For more information, or to learn how to change your cookies preferences, please click here.